These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 11855567)
1. Outcome of orthotopic liver transplantation in patients with hepatitis C. Paik SW; Tan HP; Klein AS; Boitnott JK; Thuluvath PJ Dig Dis Sci; 2002 Feb; 47(2):450-5. PubMed ID: 11855567 [TBL] [Abstract][Full Text] [Related]
2. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience. Ghobrial RM; Farmer DG; Baquerizo A; Colquhoun S; Rosen HR; Yersiz H; Markmann JF; Drazan KE; Holt C; Imagawa D; Goldstein LI; Martin P; Busuttil RW Ann Surg; 1999 Jun; 229(6):824-31; discussion 831-3. PubMed ID: 10363896 [TBL] [Abstract][Full Text] [Related]
3. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175 [TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients. Jacob DA; Neumann UP; Bahra M; Klupp J; Puhl G; Neuhaus R; Langrehr JM Clin Transplant; 2006; 20(2):211-20. PubMed ID: 16640529 [TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up. Neumann UP; Berg T; Bahra M; Puhl G; Guckelberger O; Langrehr JM; Neuhaus P Transplantation; 2004 Jan; 77(2):226-31. PubMed ID: 14742986 [TBL] [Abstract][Full Text] [Related]
8. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061 [TBL] [Abstract][Full Text] [Related]
9. Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months. Ramirez CB; Doria C; di Francesco F; Iaria M; Kang Y; Marino IR J Surg Res; 2007 Apr; 138(2):198-204. PubMed ID: 17292404 [TBL] [Abstract][Full Text] [Related]
10. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation. Cimsit B; Assis D; Caldwell C; Arvelakis A; Taddei T; Kulkarni S; Schilsky M; Emre S Transplant Proc; 2011 Apr; 43(3):905-8. PubMed ID: 21486625 [TBL] [Abstract][Full Text] [Related]
11. Graft loss following liver transplantation in patients with chronic hepatitis C. Rosen HR; O'Reilly PM; Shackleton CR; McDiarmid S; Holt C; Busuttil RW; Martin P Transplantation; 1996 Dec; 62(12):1773-6. PubMed ID: 8990361 [TBL] [Abstract][Full Text] [Related]
12. Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft. Sánchez-Fueyo A; Restrepo JC; Quintó L; Bruguera M; Grande L; Sánchez-Tapias JM; Rodés J; Rimola A Transplantation; 2002 Jan; 73(1):56-63. PubMed ID: 11792978 [TBL] [Abstract][Full Text] [Related]
13. Liver transplantation for hepatitis B and C virus-related cirrhosis: mid-term results. Manzia TM; Di Paolo D; Sforza D; Toti L; Angelico R; Brega A; Angelico M; Tisone G Transplant Proc; 2010 May; 42(4):1200-3. PubMed ID: 20534261 [TBL] [Abstract][Full Text] [Related]
14. Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival. Jacob DA; Neumann UP; Bahra M; Langrehr JM; Neuhaus P Transplant Proc; 2005 May; 37(4):1691-2. PubMed ID: 15919432 [TBL] [Abstract][Full Text] [Related]
15. The effect of immunosuppressive regimens on the recurrence of primary biliary cirrhosis after liver transplantation. Levitsky J; Hart J; Cohen SM; Te HS Liver Transpl; 2003 Jul; 9(7):733-6. PubMed ID: 12827561 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis C viral infection in liver transplantation. Johnson MW; Washburn WK; Freeman RB; FitzMaurice SE; Dienstag J; Basgoz N; Jenkins RL; Cosimi AB Arch Surg; 1996 Mar; 131(3):284-91. PubMed ID: 8611094 [TBL] [Abstract][Full Text] [Related]
17. Recurrence of primary sclerosing cholangitis in patients after liver transplantation. Ołdakowska-Jedynak U; Nowak M; Mucha K; Foroncewicz B; Nyckowski P; Zieniewicz K; Ziarkiewicz-Wróblewska B; Patkowski W; Górnicka B; Paczkowska A; Michałowicz B; Pilecki T; Pawlak J; Krawczyk M; Paczek L Transplant Proc; 2006; 38(1):240-3. PubMed ID: 16504713 [TBL] [Abstract][Full Text] [Related]
18. Does tacrolimus offer virtual freedom from chronic rejection after primary liver transplantation? Risk and prognostic factors in 1,048 liver transplantations with a mean follow-up of 6 years. Jain A; Demetris AJ; Kashyap R; Blakomer K; Ruppert K; Khan A; Rohal S; Starzl TE; Fung JJ Liver Transpl; 2001 Jul; 7(7):623-30. PubMed ID: 11460230 [TBL] [Abstract][Full Text] [Related]
19. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center. Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421 [TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of patients infected with hepatitis C virus infection on survival after primary liver transplantation under tacrolimus. Casavilla FA; Rakela J; Kapur S; Irish W; McMichael J; Demetris AJ; Starzl TE; Fung JJ Liver Transpl Surg; 1998 Nov; 4(6):448-54. PubMed ID: 9791154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]